Table I.
Association between miR-1301-3p expression and the clinicopathological characteristics of patients with non-small cell lung cancer (n=124).
Characteristic | Patient, n | Low miR-1301-3p expression (n=51) | High miR-1301-3p expression (n=73) | P-value |
---|---|---|---|---|
Age, years | 0.704 | |||
<60 | 59 | 30 | 29 | |
≥60 | 65 | 21 | 44 | |
Sex | 0.453 | |||
Male | 70 | 31 | 39 | |
Female | 54 | 20 | 34 | |
TNM stage | 0.025a | |||
I–II | 86 | 39 | 47 | |
III–IV | 38 | 12 | 26 | |
Lymph node metastasis | 0.027a | |||
Negative | 84 | 34 | 50 | |
Positive | 40 | 17 | 23 | |
Differentiation | 0.136 | |||
Well-moderate | 79 | 39 | 40 | |
Poor | 45 | 12 | 33 | |
Smoking | 0.270 | |||
No | 61 | 23 | 38 | |
Yes | 63 | 28 | 35 | |
Tumor size, cm | 0.262 | |||
<4 | 67 | 35 | 32 | |
≥4 | 57 | 16 | 41 |
P<0.05. miR, microRNA; TNM, tumor-node-metastasis.